24 / June / 2026 When science turns on those who get it right The Economist journalist Matt Kaplan explores why scientific paradigms are so resistant to change—and the price paid by researchers who dare challenge the consensus By Diogo Rodriguez
03 / June / 2026 Daraxonrasib: the story of a drug that took 44 years to develop A New York Times report chronicles four decades of research culminating in the development of daraxonrasib, a drug that doubled the overall survival of patients with metastatic pancreatic cancer By Diogo Rodriguez
19 / March / 2026 A six-million-year story that explains why we speak A cognitive archaeologist pieces together the evolutionary puzzle of human language, while a monologue by Gregório Duvivier complements the experience By Marcos Buckeridge
24 / February / 2026 Breast cancer, science, and autonomy: Why read Quando a Vida Pede Coragem Historian transforms her experience with cancer into a critical reflection on evidence-based medicine, information overload, and patient agency. By Bruno de Pierro
03 / February / 2026 Causal inference beyond statistics Classic article shows that establishing cause-and-effect relationships requires theory, context, and multiple sources of evidence—not just good statistical models By Thiago Cerqueira Silva
16 / January / 2026 Ignored risk: NEJM issues warning about smokeless tobacco Smokeless tobacco accounts for a significant share of oral cancer cases worldwide, warns influential medical journal By Bruno de Pierro
06 / November / 2025 Authors propose new perspective on dialogue between different knowledge areas Newly published work seeks to reexamine the connection between different forms of knowledge based on the concept of “partial overlaps” By Bruno de Pierro
26 / March / 2025 A key read for understanding the coma Publication has become a reference in neurology by examining underlying mechanisms in the coma and other consciousness disorders By Gisele Sampaio Silva
14 / February / 2025 Behind the scenes of gene editing Walter Isaacson’s work is essential to understanding the ways biochemist Jennifer Doudna contributed to the development of CRISPR-Cas9 By Davi Coe Torres
30 / July / 2024 The role of microbiota and obesity in cancer Brazilian molecular biologist explains study that traces the correlation between microbiota and obesity in more advanced diseases with worse prognoses By Emmanuel Dias-Neto
